Caixin
Oct 29, 2021 08:00 AM

Shenzhen Bioeasy Biotechnology Co.,Ltd.’s Net Profit Rose 276.9% in First Three Quarters of 2021

Shenzhen Bioeasy Biotechnology Co.,Ltd. (深圳市易瑞生物技术股份有限公司) (300942.SZ) reported a net profit of 195.6 million yuan in the first three quarters of 2021, up 276.9% year-on-year.

Meanwhile, the company posted 431.1 million yuan in revenue, up 131.1% year-on-year.

At the end of the reporting period, it had 1.1 billion yuan in total assets and 205.9 million yuan in total liabilities, with a liability-to-asset ratio of 18.6%.

This article was automatically produced by Caixin Automation on Nov. 3, 2021.

Download our app to receive breaking news alerts and read the news on the go.

Follow the Chinese markets in real time with Caixin Global’s new stock database.

Share this article
Open WeChat and scan the QR code
NEWSLETTERS
Get our CX Daily, weekly Must-Read and China Green Bulletin newsletters delivered free to your inbox, bringing you China's top headlines.

We ‘ve added you to our subscriber list.

Manage subscription
PODCAST
Caixin China Biz Roundup: Chinese Ambassador Warns U.S. Against Meddling in Taiwan
00:00
00:00/00:00